Beijing Cooperate Pharmaceutical Co.,Ltd
Beijing Cooperate Pharmaceutical Co., Ltd., commonly referred to as Cooperate Pharma, is a leading player in the pharmaceutical industry, headquartered in Beijing, China. Established in 2003, the company has made significant strides in the development and distribution of high-quality pharmaceutical products, primarily focusing on generic medications and active pharmaceutical ingredients (APIs). With a strong presence in both domestic and international markets, Cooperate Pharma has built a reputation for innovation and reliability. Its core offerings include a diverse range of therapeutic solutions that cater to various medical needs, setting them apart through rigorous quality control and adherence to international standards. Recognised for its commitment to excellence, Beijing Cooperate Pharmaceutical has achieved notable milestones, positioning itself as a trusted partner in healthcare. The company continues to expand its operational footprint, contributing to advancements in global health.
DitchCarbon Score
How does Beijing Cooperate Pharmaceutical Co.,Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Beijing Cooperate Pharmaceutical Co.,Ltd's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Beijing Cooperate Pharmaceutical Co.,Ltd's reported carbon emissions
Beijing Cooperate Pharmaceutical Co., Ltd, headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. As there are no emissions or reduction initiatives reported, it is unclear how Beijing Cooperate Pharmaceutical is addressing its carbon footprint or contributing to climate action within the pharmaceutical sector. The lack of data may reflect a broader industry context where many companies are still developing their sustainability strategies and emissions reporting frameworks. In summary, without available emissions data or climate commitments, it is difficult to assess Beijing Cooperate Pharmaceutical's impact on climate change or its dedication to reducing carbon emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Beijing Cooperate Pharmaceutical Co.,Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
